For more information or confidential assistance
800-306-3180
se habla español

MDL Centralization Sought for Valsartan Litigation

A motion was recently filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) that seeks to consolidate federal complaints filed with regard to valsartan, a generic hypertension drug. The motion was filed late in October 2018 by Robert Kruk on behalf of himself and other plaintiffs with pending valsartan lawsuits. Kruk... Read more »

Fresenius Announces $250 Million Granuflo Settlement

Fresenius Medical Care North America agreed to a $250 million settlement to resolve lawsuits that claim the company was aware of risks of their dialysis products yet failed to warn the public. The litigation centers upon Granuflo and Naturalyte, two dialysates that have been blamed for heart problems, strokes and death... Read more »

Granuflo Wrongful Death Claim Joins MDL 2428

Accusations leveled in a recent Granuflo lawsuit state that plaintiff William Cox died as an alleged result of his exposure to the dialysate. The short form complaint was filed directly into the Fresenius Granuflo/Naturalyte Dialysate Products Liability Litigation on April 22, 2015. Debra Phelps is the anticipated personal representative of... Read more »

New Fresenius Dialysis Lawsuit Joins MDL 2428

Mason v. Fresenius Medical Care Holdings, Inc. was filed directly into multidistrict litigation (MDL 2428) on December 10, 2014, joining thousands of similar claims that allege Granuflo and Naturalyte dialysis additives are defective and unreasonably dangerous. Plaintiff Robert Mason brought his product liability complaint individually and on behalf of the... Read more »